Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K
Cancer Vaccines01:30

Cancer Vaccines

347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

228
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
228

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023.

JAMA cardiology·2026
Same author

Incidence of Dengue Fever in Pakistan.

PloS one·2026
Same author

Measuring antenatal care timing and content across 131 low-income and middle-income countries, 1995-2023: a systematic analysis of trends.

The Lancet. Global health·2026
Same author

Correction: Racial disparity in mortality from tuberculosis in the US between states with and without a history of Jim‑Crow laws: an analysis of the Global Burden of Disease (GBD) and risk factors study, 1990 to 2019.

BMC public health·2026
Same author

Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019.

Journal of the National Cancer Institute·2026
Same author

Burden of non-communicable diseases among adolescents and young adults aged 10-24 years in Middle East and North Africa, 1990-2023: a systematic analysis of the Global Burden of Diseases Study 2023.

EClinicalMedicine·2026

相关实验视频

Updated: Jun 16, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K

创建疫苗接种改善潜力指数.

Francisco Rios Casas1, Jacob Armitage1, Joanna Yuan1

  • 1Population Health Initiative, Hans Rosling Center for Population Health, University of Washington, Box 351622, 3980 15th Ave NE, Seattle, WA, 98195, USA.

Heliyon
|August 16, 2024
PubMed
概括

一个新的疫苗接种改善潜力 (VIP) 指数有助于评估各国提高免疫率的能力. 该指数使用卫生融资和社会人口统计数据,显示了随着时间的推移的改善,指导了全球疫苗接种工作的资源配置.

更多相关视频

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

相关实验视频

Last Updated: Jun 16, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

科学领域:

  • 全球健康 全球健康
  • 公共卫生政策 公共卫生政策
  • 免疫接种计划 免疫接种计划

背景情况:

  • 社会和行为因素显著影响全球疫苗接种覆盖率.
  • 现有的措施并不能全面反映一个国家提高或维持免疫覆盖率的能力.

研究的目的:

  • 引入和验证疫苗接种改善潜力 (VIP) 指数,这是一个评估一个国家提高疫苗接种覆盖率潜力的新型指标.
  • 分析30年来各国疫苗接种改善潜力的趋势.

主要方法:

  • 该VIP指数是使用与卫生融资,疫苗信心和社会人口统计相关的13个指标的几何平均值来计算的.
  • 数据涵盖了超过200个国家的30年时间,从1990年到2019年.

主要成果:

  • 全球平均VIP分数从1990年的0.49增加到2019年的0.59.
  • 高绩效地区包括西欧,北美和东亚.
  • 影响趋势的关键因素包括疫苗犹和卫生支出和发展援助的差异,特别是在撒哈拉以南非洲.

结论:

  • "VIP指数"为评估一个国家实现更高免疫率的能力提供了一个独特的工具.
  • 该指数可以为决策者和卫生官员提供资源分配,影响评估和识别需要支持改善疫苗接种覆盖率的国家的信息.